Hydrochloric Acid

Hydrochloric Acid

SCHEMBL652610

CC(OC(=O)OC1CCCCC1)OC(=O)C1C=CC=C2Oc3ncccc3C(=CCCN3CCC(O)(c4ccc(Cl)cc4)CC3)C=C21.Cl.Cl

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 4/20 0.31
ADRB2 known ✓ P07550 1/20 0.30
ADRA2A known ✓ P08913 1/20 0.30
DRD4 known ✓ P21917 1/20 0.30
HTR1D known ✓ P28221 1/20 0.30
SLC6A4 known ✓ P31645 1/20 0.30
ADRA1B known ✓ P35368 1/20 0.30
OPRD1 known ✓ P41143 1/20 0.30
OPRK1 known ✓ P41145 1/20 0.30
HTR2B known ✓ P41595 1/20 0.30
SLC6A3 known ✓ Q01959 1/20 0.30
SIGMAR1 known ✓ Q99720 1/20 0.30
OPRL1 P41146 2/20 0.31
MEN1 O00255 1/20 0.30
GMNN O75496 1/20 0.30
LMNA P02545 1/20 0.30
FPR1 P21462 1/20 0.30
C5AR1 P21730 1/20 0.30
FPR2 P25090 1/20 0.30
GPR183 P32249 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL655960 0.91 OPRM1 (0.35) OPRM1OPRL1MEN1LMNAADRB2
SCHEMBL654000 0.91 OPRM1 (0.34) OPRM1OPRL1MEN1LMNAADRB2
SCHEMBL654271 0.90 CCR1 (0.34) OPRM1OPRL1CCR1
SCHEMBL653214 0.89 OPRM1 (0.35) OPRM1OPRL1MEN1GMNNLMNA
SCHEMBL655073 0.84 CCR1 (0.37) OPRM1OPRL1MEN1GMNNLMNA
SCHEMBL658798 0.84 CCR1 (0.35) OPRM1OPRL1MEN1LMNAADRB2
SCHEMBL654382 0.84 DRD2 (0.35) OPRM1OPRL1MEN1GMNNLMNA
SCHEMBL655037 0.84 DRD2 (0.38) OPRM1OPRL1MEN1LMNAADRB2
SCHEMBL653476 0.83 OPRM1 (0.35) OPRM1OPRL1MEN1LMNAADRB2
SCHEMBL655209 0.82 DRD2 (0.34) OPRM1OPRL1MEN1GMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9926478-B2 Highly durable superhydrophobic, oleophobic and anti-icing coatings and methods and compositions for their preparation ROSS TECHNOLOGY CORPORATION (US) 2018-03-27 US disclosed
EP-2346678-B1 SPILL RESISTANT SURFACES HAVING HYDROPHOBIC AND OLEOPHOBIC BORDERS ROSS TECH CORP (US) 2017-10-04 EP disclosed
US-20170038127-A1 Spill Resistant Surfaces Having Hydrophobic and Oleophobic Borders ADT TECHNOLOGY LLC 2017-02-09 US disclosed
US-20160289810-A1 Highly Durable Superhydrophobic, Oleophobic and Anti-Icing Coatings and Methods and Compositions for Their Preparation ADT TECHNOLOGY LLC 2016-10-06 US disclosed
US-9243175-B2 Spill resistant surfaces having hydrophobic and oleophobic borders ROSS TECHNOLOGY CORPORATION (US) 2016-01-26 US disclosed
US-9096786-B2 Spill resistant surfaces having hydrophobic and oleophobic borders ROSS TECHNOLOGY CORPORATION (US) 2015-08-04 US disclosed
US-9067821-B2 Highly durable superhydrophobic, oleophobic and anti-icing coatings and methods and compositions for their preparation ROSS TECHNOLOGY CORPORATION (US) 2015-06-30 US disclosed
US-20150097475-A1 Spill Resistant Surfaces Having Hydrophobic and Oleophobic Borders SSW ADVANCED TECHNOLOGIES, LLC 2015-04-09 US disclosed
US-20120045954-A1 HIGHLY DURABLE SUPERHYDROPHOBIC. OLEOPHOBIC AND ANTI-ICING COATINGS AND METHODS AND COMPOSITIONS FOR THEIR PREPARATION ROSS TECHNOLOGY CORPORATION (US) 2012-02-23 US disclosed
US-20120009396-A1 SPILL RESISTANT SURFACES HAVING HYDROPHOBIC AND OLEOPHOBIC BORDERS ROSS TECHNOLOGY CORPORATION (US) 2012-01-12 US disclosed
US-20050070549-A1 Chemokine receptor antagonists and methods of use thereof KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070549-A1 Chemokine receptor antagonists and methods of use thereof ACKR3, CXCR2, CCL11 OPRM1 443/4885ADRB2 458/4885ADRA2A 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.